ConductScience.org, home

Paper33536635

Trends in peptide drug discovery.

Muttenthaler M and 3 others. Nat Rev Drug Discov, 2021. Cited by 1,431 papers, by iCite.

Cite this record

ConductScience Library. Trends in peptide drug discovery. Papers, record 33536635. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33536635

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Trends in peptide drug discovery.
PubMed
Journal
Nat Rev Drug Discov
PubMed
Year
2021
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
1,431
iCite
Relative citation ratio, by iCite
98.7
iCite
Revised in PubMed
2026-10-10
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Muttenthaler MMarkushttps://orcid.org/0000-0003-1996-4646
2King GFGlenn Fhttps://orcid.org/0000-0002-2308-2200
3Adams DJDavid Jhttps://orcid.org/0000-0002-7030-2288
4Alewood PFPaul Fhttps://orcid.org/0000-0001-7454-6522

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Drug DevelopmentMajor topic
Drug DiscoveryMajor topic
PeptidesMajor topic
Animals
Chemistry, Pharmaceutical
Drug Design
Humans
Peptide Library

Source PubMed

Download CSV of topics

References232

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
112145241Pharmacokinetics, pharmacodynamics, safety, and tolerability of a single-dose of NN2211, a long-acting glucagon-like peptide 1 derivative, in healthy male subjects.Diabetes Care2002https://conductscience.org/library/papers/12145241PubMed
225340933Targeting receptor-mediated transport for delivery of biologics across the blood-brain barrier.Annu Rev Pharmacol Toxicol2015https://conductscience.org/library/papers/25340933PubMed
38969Biological effects of cyclosporin A: a new antilymphocytic agent.Agents Actions1976https://conductscience.org/library/papers/8969PubMed
429395804Peptide chemistry toolbox - Transforming natural peptides into peptide therapeutics.Bioorg Med Chem2018https://conductscience.org/library/papers/29395804PubMed
523593142Glucose-reducing effect of the ORMD-0801 oral insulin preparation in patients with uncontrolled type 1 diabetes: a pilot study.PLoS One2013https://conductscience.org/library/papers/23593142PubMed
621939428Venoms as a platform for human drugs: translating toxins into therapeutics.Expert Opin Biol Ther2011https://conductscience.org/library/papers/21939428PubMed
723090647
Pharmacologic properties, metabolism, and disposition of linaclotide, a novel therapeutic peptide approved for the treatment of irritable bowel syndrome with constipation and chronic idiopathic constipation.
J Pharmacol Exp Ther2013https://conductscience.org/library/papers/23090647PubMed
84734245The use of mass spectrometry in deducing the sequence of somatostatin--a hypothalamic polypeptide that inhibits the secretion of growth hormone.Biochem Biophys Res Commun1973https://conductscience.org/library/papers/4734245PubMed
924566540Gastrointestinal hormones and the dialogue between gut and brain.J Physiol2014https://conductscience.org/library/papers/24566540PubMed
102374926The structure of a complex of recombinant hirudin and human alpha-thrombin.Science1990https://conductscience.org/library/papers/2374926PubMed
1112815383Large-scale manufacture of peptide therapeutics by chemical synthesis.Nat Rev Drug Discov2003https://conductscience.org/library/papers/12815383PubMed
12266179Relative conformational rigidity in oxytocin and (1-penicillamine)-oxytocin: a proposal for the relationship of conformational flexibility to peptide hormone agonism and antagonism.Proc Natl Acad Sci U S A1977https://conductscience.org/library/papers/266179PubMed
133783079Synthetic antagonists of the myometrial response to vasopressin and oxytocin.J Endocrinol1986https://conductscience.org/library/papers/3783079PubMed
1421117646Modulating oxytocin activity and plasma stability by disulfide bond engineering.J Med Chem2010https://conductscience.org/library/papers/21117646PubMed
1523817290Current and future applications of GnRH, kisspeptin and neurokinin B analogues.Nat Rev Endocrinol2013https://conductscience.org/library/papers/23817290PubMed
1616382097Overview of molecular relationships in the voltage-gated ion channel superfamily.Pharmacol Rev2005https://conductscience.org/library/papers/16382097PubMed
1718215771Messenger RNA-programmed incorporation of multiple N-methyl-amino acids into linear and cyclic peptides.Chem Biol2008https://conductscience.org/library/papers/18215771PubMed
1832087818Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial.Lancet2020https://conductscience.org/library/papers/32087818PubMed
1926988411Pursuit of a perfect insulin.Nat Rev Drug Discov2016https://conductscience.org/library/papers/26988411PubMed
2031083077Efficacy and Safety of AM-111 in the Treatment of Acute Unilateral Sudden Deafness-A Double-blind, Randomized, Placebo-controlled Phase 3 Study.Otol Neurotol2019https://conductscience.org/library/papers/31083077PubMed

See all 232 referencesDownload CSV of references

Cited by807

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,431 citations.

PMIDTitleJournalYearIn PapersSource
42963318A Novel Peptide Targeting the USP25-SIRT1 Interaction Activates SIRT1 to Suppress Cell Senescence.Aging Cell2026https://conductscience.org/library/papers/42963318PubMed
42957812Physicochemical rule-embedded generative modeling for constrained peptide therapeutics.NPJ Drug Discov2026https://conductscience.org/library/papers/42957812PubMed
42948721Antibody peptide conjugates as multifunctional therapeutics: Mechanisms, challenges, and prospects.Acta Pharm Sin B2026https://conductscience.org/library/papers/42948721PubMed
42948390HXZQCG: A database of natural diverse components in polyherbal formulation HXZQ identified naringenin chalcone as a ligand of H2R.Chin Herb Med2026https://conductscience.org/library/papers/42948390PubMed
42946816In situ assembly of peptides in living cells.Nat Protoc2026https://conductscience.org/library/papers/42946816PubMed
42942837The Stability-Release Paradox in Long-Acting Peptide and Protein Delivery: A Review of Material-Cargo Compatibility and Therapeutic Integrity.Pharmaceutics2026https://conductscience.org/library/papers/42942837PubMed
42942740Peptide-Based Molecular Glues for Targeted Protein Degradation.Pharmaceutics2026https://conductscience.org/library/papers/42942740PubMed
42939699Artificial Intelligence for Therapeutic Peptide Discovery and Development.Biomolecules2026https://conductscience.org/library/papers/42939699PubMed
42937831Metal-Dependent Coordination Geometry Controls Autolytic Amide Bond Cleavage to Enable Prodrug Activation.J Am Chem Soc2026https://conductscience.org/library/papers/42937831PubMed
42936106Exertional heat stroke induces liver injury through the activation of the TLR4/NF-κB signaling pathway.Biochem Biophys Rep2026https://conductscience.org/library/papers/42936106PubMed
42934284Enzymatic installation of post-translational modifications into artificial peptides using RiPP biosynthetic machinery.J Antibiot (Tokyo)2026https://conductscience.org/library/papers/42934284PubMed
42931502Venoms and Drugs: Advancing Venom-Based Therapeutics from Molecular Insights to Translational Applications.Toxins (Basel)2026https://conductscience.org/library/papers/42931502PubMed
42920736Establishing standardized evaluation protocols for peptide-target interaction prediction: the PTI-TAPE consensus framework eDelphi.Front Bioinform2026https://conductscience.org/library/papers/42920736PubMed
42918117Systematic Characterization of Thermal Stability Assay Parameters and Application in Discovery of Peptide-Protein Interactions.J Proteome Res2026https://conductscience.org/library/papers/42918117PubMed
42912342General Asymmetric Synthesis of Noncanonical Amino Acids.J Am Chem Soc2026https://conductscience.org/library/papers/42912342PubMed
42903480A roadmap for exploring the untouched protein space for biology and medicine.Hlife2023https://conductscience.org/library/papers/42903480PubMed
42898872The chromosome-level genome of Mesobuthus martensii provides insights into its evolution and the diversity of venom peptides.Pharm Sci Adv2026https://conductscience.org/library/papers/42898872PubMed
42893140Peptide-Mediated Precise Intracellular Delivery of Bioactive Substances.Int J Nanomedicine2026https://conductscience.org/library/papers/42893140PubMed
42883905Structure-Based Engineering for PTPσ-Targeted Therapeutic Development.Int J Mol Sci2026https://conductscience.org/library/papers/42883905PubMed
42883427Rational Design and Delivery of Engineered Peptides: Toward a Unified Framework for Structure, Screening, and Application.Biology (Basel)2026https://conductscience.org/library/papers/42883427PubMed

See all 807 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
INS3630PubTator's text mininghttps://conductscience.org/library/genes/3630

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33536635

GET https://conductscience.org/api/papers/v1/33536635/references?page=2